These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21215749)

  • 1. Alternative complement pathway assessment in patients with atypical HUS.
    Roumenina LT; Loirat C; Dragon-Durey MA; Halbwachs-Mecarelli L; Sautes-Fridman C; Fremeaux-Bacchi V
    J Immunol Methods; 2011 Feb; 365(1-2):8-26. PubMed ID: 21215749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway.
    Rodríguez de Córdoba S; Harris CL; Morgan BP; Llorca O
    Biochim Biophys Acta; 2011 Jan; 1812(1):12-22. PubMed ID: 20837143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?
    Marinozzi MC; Vergoz L; Rybkine T; Ngo S; Bettoni S; Pashov A; Cayla M; Tabarin F; Jablonski M; Hue C; Smith RJ; Noris M; Halbwachs-Mecarelli L; Donadelli R; Fremeaux-Bacchi V; Roumenina LT
    J Am Soc Nephrol; 2014 Sep; 25(9):2053-65. PubMed ID: 24652797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.
    Roumenina LT; Frimat M; Miller EC; Provot F; Dragon-Durey MA; Bordereau P; Bigot S; Hue C; Satchell SC; Mathieson PW; Mousson C; Noel C; Sautes-Fridman C; Halbwachs-Mecarelli L; Atkinson JP; Lionet A; Fremeaux-Bacchi V
    Blood; 2012 May; 119(18):4182-91. PubMed ID: 22246034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Hematol; 2010 Sep; 17(5):432-8. PubMed ID: 20613506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
    Goicoechea de Jorge E; Harris CL; Esparza-Gordillo J; Carreras L; Arranz EA; Garrido CA; López-Trascasa M; Sánchez-Corral P; Morgan BP; Rodríguez de Córdoba S
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):240-5. PubMed ID: 17182750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. aHUS caused by complement dysregulation: new therapies on the horizon.
    Waters AM; Licht C
    Pediatr Nephrol; 2011 Jan; 26(1):41-57. PubMed ID: 20556434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
    Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M; Caprioli J; Bresin E; Mossali C; Pianetti G; Gamba S; Daina E; Fenili C; Castelletti F; Sorosina A; Piras R; Donadelli R; Maranta R; van der Meer I; Conway EM; Zipfel PF; Goodship TH; Remuzzi G
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M; Zuber J; Moulin B; Kamar N; Jablonski M; Lionet A; Chatelet V; Mousson C; Mourad G; Bridoux F; Cassuto E; Loirat C; Rondeau E; Delahousse M; Frémeaux-Bacchi V
    Am J Transplant; 2013 Mar; 13(3):663-75. PubMed ID: 23356914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.
    Frimat M; Tabarin F; Dimitrov JD; Poitou C; Halbwachs-Mecarelli L; Fremeaux-Bacchi V; Roumenina LT
    Blood; 2013 Jul; 122(2):282-92. PubMed ID: 23692858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement therapy in atypical haemolytic uraemic syndrome (aHUS).
    Wong EK; Goodship TH; Kavanagh D
    Mol Immunol; 2013 Dec; 56(3):199-212. PubMed ID: 23810412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
    Dragon-Durey MA; Frémeaux-Bacchi V
    Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.